Checkmate Pharmaceuticals Inc. (CMPI): Price and Financial Metrics Recent IPO

Checkmate Pharmaceuticals Inc. (CMPI) Recent IPO

Today's Latest Price: $11.00 USD

0.04 (0.36%)

Updated Nov 24 4:00pm

Add CMPI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CMPI Stock Price Chart Interactive Chart >

Price chart for CMPI

CMPI Price/Volume Stats

Current price $11.00 52-week high $16.49
Prev. close $10.96 52-week low $8.61
Day low $10.76 Volume 13,100
Day high $11.51 Avg. volume 52,751
50-day MA $11.34 Dividend yield N/A
200-day MA $0.00 Market Cap 237.06M

Checkmate Pharmaceuticals Inc. (CMPI) Company Bio

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.

CMPI Latest News Stream

Event/Time News Detail
Loading, please wait...

CMPI Latest Social Stream

Loading social stream, please wait...

View Full CMPI Social Stream

Latest CMPI News From Around the Web

Below are the latest news stories about Checkmate Pharmaceuticals Inc that investors may wish to consider to help them evaluate CMPI as an investment opportunity.

Checkmate Pharmaceuticals reports Q2 results

Checkmate Pharmaceuticals (CMPI): Q2 net loss of $8.3MPress Release...

Seeking Alpha | September 18, 2020

Read More 'CMPI' Stories Here

CMPI Price Returns

1-mo -7.17%
3-mo -29.03%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.822 seconds.